Page 59 - Vitamin D and Cancer

46 J. Thorne and M.J. Campbell

56. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD (1995) Two classes of proteins dependent
on either the presence or absence of thyroid hormone for interaction with the thyroid hor-
mone receptor. Mol Endocrinol 9:243–254
57. Zhang C et al (2003) Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-
associated coactivator that may couple vitamin D receptor-mediated transcription and RNA
splicing. J Biol Chem 278:35325–35336
58. Urahama N et al (2005) The role of transcriptional coactivator TRAP220 in myelomonocytic
differentiation. Genes Cells 10:1127–1137
59. Ren Y et al (2000) Specific structural motifs determine TRAP220 interactions with nuclear
hormone receptors. Mol Cell Biol 20:5433–5446
60. Teichert A et al (2009) Quantification of the Vitamin D Receptor-Coregulator Interaction
(dagger). Biochemistry 48(7):1254–61
61. Hawker NP, Pennypacker SD, Chang SM, Bikle DD (2007) Regulation of human epidermal
keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2,
and SRC3. J Invest Dermatol 127:874–880
62. Lutz W, Kohno K, Kumar R (2001) The role of heat shock protein 70 in vitamin D receptor
function. Biochem Biophys Res Commun 282:1211–1219
63. Guzey M, Takayama S, Reed JC (2000) BAG1L enhances trans-activation function of the
vitamin D receptor. J Biol Chem 275:40749–40756
64. Bikle D, Teichert A, Hawker N, Xie Z, Oda Y (2007) Sequential regulation of keratinocyte
differentiation by 1, 25(OH)2D3, VDR, and its coregulators. J Steroid Biochem Mol Biol
103:396–404
65. Blok LJ, de Ruiter PE, Brinkmann AO (1996) Androgen receptor phosphorylation. Endocr
Res 22:197–219
66. Hilliard GMT, Cook RG, Weigel NL, Pike JW (1994) 1, 25-dihydroxyvitamin D3 modulates
phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of
this residue promotes alternative phosphorylation. Biochemistry 33:4300–4311
67. Hsieh JC et al (1991) Human vitamin D receptor is selectively phosphorylated by protein
kinase C on serine 51, a residue crucial to its trans-activation function. Proc Natl Acad Sci
USA 88:9315–9319
68. Macoritto M et al (2008) Phosphorylation of the human retinoid X receptor alpha at serine
260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands.
J Biol Chem 283:4943–4956
69. Arriagada G et al (2007) Phosphorylation at serine 208 of the 1[alpha], 25-dihydroxy vita-
min D3 receptor modulates the interaction with transcriptional coactivators. J Steroid
Biochem Mol Biol 103:425–429
70. Jurutka PW et al (1996) Human vitamin D receptor phosphorylation by casein kinase II at
Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci USA 93:3519–3524
71. Barletta F, Freedman LP, Christakos S (2002) Enhancement of VDR-mediated transcription
by phosphorylation: correlation with increased interaction between the VDR and DRIP205,
a subunit of the VDR-interacting protein coactivator complex. Mol Endocrinol 16:301–314
72. Carlberg C, Seuter S (2007) The vitamin D receptor. Dermatol Clin 25:515–523, viii
73. Thompson PD et al (2002) Liganded VDR induces CYP3A4 in small intestinal and colon
cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res
Commun 299:730–738
74. Song CS et al (2006) An essential role of the CAAT/enhancer binding protein-alpha in the
vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Mol Endocrinol 20:795–808
75. Rosenfeld MG, Lunyak VV, Glass CK (2006) Sensors and signals: a coactivator/corepressor/
epigenetic code for integrating signal-dependent programs of transcriptional response. Genes
Dev 20:1405–1428
76. Chen CD et al (2004) Molecular determinants of resistance to antiandrogen therapy. Nat
Med 10:33–39